tiprankstipranks
Trending News
More News >
CNBX Pharmaceuticals (CNBX)
OTHER OTC:CNBX
US Market
Advertisement

CNBX Pharmaceuticals (CNBX) Income Statement

Compare
122 Followers

CNBX Pharmaceuticals Income Statement

Last quarter (Q3 2025), CNBX Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, CNBX Pharmaceuticals's net income was $-59.73K. See CNBX Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 130.07K$ 410.17K$ 29.96K$ 0.00
Gross Profit
$ 0.00$ 130.07K$ 410.17K$ -169.00K$ -221.00K
Operating Expenses
$ 271.69K$ 713.21K$ 1.34M$ 2.79M$ 2.60M
Depreciation and Amortization
$ 0.00$ 72.32K$ 162.06K$ 198.53K$ 220.93K
EBITDA
$ -271.69K$ -603.00K$ -3.55M$ -3.52M$ -2.91M
Operating Income
$ -271.69K$ -583.00K$ -931.00K$ -2.95M$ -2.60M
Other Income/Expenses
$ -42.28K$ -112.00K$ -2.78M$ -1.39M$ -594.00K
Pretax Income
$ -313.98K$ -695.00K$ -3.71M$ -4.35M$ -3.19M
Net Income
$ -313.98K$ -695.00K$ -3.71M$ -3.72M$ -3.19M
Per Share Metrics
Basic EPS
$ 0.00$ -0.02$ -0.42$ -3.59$ -2.16
Diluted EPS
$ 0.00$ -0.02$ -0.42$ -3.59$ -2.16
Weighted Average Shares Outstanding
90.65M 30.25M 8.82M 1.22M 1.15M
Weighted Average Shares Outstanding (Diluted)
90.65M 30.25M 8.82M 1.22M 1.15M
Currency in USD

CNBX Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis